In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program (Q30612482)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

1 reference

Europe PubMed Central

In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

antibiotic resistance

0 references

antimicrobial resistance

1 reference

based on heuristic

inferred from title

respiratory tract infection

1 reference

based on heuristic

inferred from title

1

object named as

Jones RN

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Michael A. Pfaller

2

object named as

Pfaller MA

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

language of work or name

0 references

publication date

1 August 2000

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

31 Suppl 2

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

S16-23

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance Program

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997).

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

The emergent needs for basic research, education, and surveillance of antimicrobial resistance. Problems facing the report from the American Society for Microbiology Task Force on Antibiotic Resistance

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

Antimicrobial activity of gatifloxacin tested against 1676 strains of ciprofloxacin-resistant gram-positive cocci isolated from patient infections in North and South America

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

Comparative activity of clinafloxacin and nine other compounds tested against 2000 contemporary clinical isolates from patients in United States hospitals.

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

The diagnosis and treatment challenges in nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

Pneumonia due to Haemophilus influenzae among mechanically ventilated patients. Incidence, outcome, and risk factors

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysis.

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds.

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

Antimicrobial activity of SCH27899 (Ziracin), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/etest method evaluations and quality control guidelines. The Quality Control Study Group.

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents. A 187 clinical laboratory center sample in the United States

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

A survey of beta-lactamase-producing Haemophilus influenzae. An evaluation of 5750 isolates

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE program

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

Nosocomial enterococcal blood stream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy

1 reference

https://api.crossref.org/works/10.1086%2F314054

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30612482&oldid=2282053623"